oral prostaglandin F receptor GCPR antagonist to treat IPF, in vivo efficacy in fibrosis model from ~3M cmpd cell-based HTS and opt. J. Med. Chem., Oct. 22, 2020 issue Bayer AG, Wuppertal, DE